Skip to main content
SpringerLink
Log in

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases)

  • IM - Debate
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ruiz-Irastorza G, Hunt BJ, Khamashta MA (2007) A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum 57:1487–1495

    Article  PubMed  Google Scholar 

  2. Erkan D, Merrill JT, Yazici Y, Sammaritano L, Buyon JP, Lockshin MD (2001) High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 44:1466–1469

    Article  PubMed  CAS  Google Scholar 

  3. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD (2002) A cross sectional study of clinical trombotic risks factors and preventive treatments in antiphospholipid syndrome. Rheumatology 41:924–929

    Article  PubMed  CAS  Google Scholar 

  4. Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD (2007) Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 56:2382–2391

    Article  PubMed  CAS  Google Scholar 

  5. Hereng T, Lambert M, Hachulla E, Samor M, Dubucquoi S, Caron C, Launay D, Morell-Dubois S, Queyrel V, Hatron PY (2008) Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus 17:11–15

    Article  PubMed  CAS  Google Scholar 

  6. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Google Scholar 

  7. Galli M, Luciani D (2003) Lupus anticoagulants are stronger risk factors of thrombosis than anti-cardiolipin antibodies in the anti-phospholipid syndrome: a systematic review of the literature. Blood 101:1827–1832

    Article  PubMed  CAS  Google Scholar 

  8. Galli M, Luciani D, Bertolini G, Barbui T (2003) Anti-beta 2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 102:2717–2723

    Article  PubMed  CAS  Google Scholar 

  9. Galli M, Borrelli G, Jacobsen EM, Marfisi RM, Finazzi G, Marchioli R, Wisloff F, Marziali S, Morboeuf O, Barbui T (2007) Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study Blood 110:1178–83

    Google Scholar 

  10. Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V (2008) Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 5 [Epub ahead of print]

  11. Giron-Gonzalez JA, Garcia Del Rio E, Rodriguez C, Rodriguez-Martorell J, Serrano A (2004) Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31:1560–1567

    PubMed  Google Scholar 

  12. Rosove MH, Brewer PM (1992) Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117:303–308

    PubMed  CAS  Google Scholar 

  13. Derksen RH, de Groot PG, Kater L, Nieuwenhuis HK (1993) Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 52:689–692

    Article  PubMed  CAS  Google Scholar 

  14. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993–997

    Article  PubMed  CAS  Google Scholar 

  15. Shah NM, Khamashta MA, Atsumi T, Hughes GR (1998) Outcome of patients with anticardiolipin antibodies: a 10-year follow-up of 52 patients. Lupus 7:3–6

    Article  PubMed  CAS  Google Scholar 

  16. Finazzi G, Brancaccio V, Moia M, Ciaverella N, Mazzucconi MG, Schinco PC, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D’Angelo A, Palareti G, De Stefano V, Berrettini M, Barbui T (1996) Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 100:530–536

    Article  PubMed  CAS  Google Scholar 

  17. Erkan D (2006) Lupus and thrombosis. J Rheumatol 33:1715–1717

    PubMed  Google Scholar 

  18. Wahl DG, Bounameaux H, de Moerloose P, Sarasin FP (2000) Prophylactic Antithrombotic Therapy for Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies Do the Benefits Outweigh the Risks? A Decision Analysis. Arch Intern Med 160:2042–2048

    Article  PubMed  CAS  Google Scholar 

  19. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Matucci Cerinic M, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112:3337–3347

    Article  PubMed  Google Scholar 

  20. Ostrowski RA, Robinson JA (2008) Antiphospholipid antibody syndrome and autoimmune diseases. Hematol Oncol Clin N Am 22:53–65

    Article  Google Scholar 

  21. Diz-Küçükkaya R, Hacihanefioğlu A, Yenerel M, Turgut M, Keskin H, Nalçaci M, Inanç M (2001) Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 98:1760–1764

    Article  PubMed  Google Scholar 

  22. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S (2005) Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351:260–267

    Article  Google Scholar 

  23. Erkan D, Patel S, Nuzzo M, Gerosa M, Tincani A, Meroni PL, Lockshin M (2008) Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (in press)

  24. Roubey RA (2003) New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials, and tribulations. Arthritis Rheum 48:3004–3008

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Allergy, Clinical Immunology and Rheumatology Unit, University of Milan, Ospedale San Luca, Via Spagnoletto, 3, 20149, Milan, Italy

    Maria Gerosa, Cecilia Chighizola & Pier Luigi Meroni

  2. IRCCS Istituto Auxologico Italiano, Milan, Italy

    Maria Gerosa, Cecilia Chighizola & Pier Luigi Meroni

Authors
  1. Maria Gerosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cecilia Chighizola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pier Luigi Meroni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pier Luigi Meroni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerosa, M., Chighizola, C. & Meroni, P.L. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases). Intern Emerg Med 3, 201–203 (2008). https://doi.org/10.1007/s11739-008-0170-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-008-0170-y

Search

Navigation